Santé
MACRILEN TM
Molecule for growth hormone dosage
Carnot Enterprise partnership Carnot Chimie Balard Cirimat Institute - AETERNA ZENTARIS
Growth hormone (GH) deficiency is attributable to a problem with the hypothalamic-pituitary axis, which may be characterised by damage to the hypothalamus or pituitary gland. Before now, there was no straightforward way to regulate the dose of the hormone produced by the pituitary gland, however, Aeterna Zentaris has come up with MacrilenTM, an orally ingestible solution.
